Stuart J. Connolly

Risk of Bleeding With 2 Doses of Dabigatran Compared With Warfarin in Older and Younger Patients With Atrial Fibrillation: An Analysis of the Randomized Evaluation of Long-Term Anticoagulant Therapy (RE-LY) Trial

S. Yusuf, M. Ezekowitz, J. Healey, 2011, Circulation.

Effect of a simple two‐step warfarin dosing algorithm on anticoagulant control as measured by time in therapeutic range: a pilot study

J. Eikelboom, S. Schulman, K. Meijer, 2010, Journal of thrombosis and haemostasis : JTH.

High prevalence of modi fi able stroke risk factors identi fi ed in a pharmacy-based screening programme

D. Conen, R. Sandhu, L. Dolovich, 2022 .

Dabigatran Versus Warfarin Effects on Ischemic and Hemorrhagic Strokes and Bleeding in Asians and Non-Asians With Atrial Fibrillation the RE-LY Investigators

P. Pais, A. Dans, M. Ezekowitz, 2013 .

Outcomes of Patients with a Mechanical Heart Valve and Poor Anticoagulation Control on Warfarin

A. Benz, J. Tyrwhitt, Nikhil Nair, 2023, Thrombosis and Haemostasis.

Major Adverse Limb Events and Mortality in Patients With Peripheral Artery Disease

J. Bosch, K. Keltai, P. Verhamme, 2018 .

Characterization of Patients with Embolic Strokes of Undetermined Source in the NAVIGATE ESUS Randomized Trial.

E. Themeles, S. Kasner, N. Bornstein, 2018, Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association.

Genetic Determinants of Dabigatran Plasma Levels and Their Relation to Bleeding Genomics

M. Ezekowitz, C. Wadelius, N. Eriksson, 2013 .

Optimizing warfarin dosing for patients with atrial fibrillation using machine learning

L. Wallentin, Shuang Di, J. Eikelboom, 2024, Scientific reports.